1995
DOI: 10.1136/gut.36.4.618
|View full text |Cite
|
Sign up to set email alerts
|

A three year follow up of self expanding metal stents in the endoscopic palliation of longterm survivors with malignant biliary obstruction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
60
2
3

Year Published

2001
2001
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 150 publications
(66 citation statements)
references
References 14 publications
1
60
2
3
Order By: Relevance
“…[1][2][3][4] As a result of advancements in therapeutic ERCP and the development of a variety of metal stents, [5][6][7][8][9] complications after stent procedures, although not frequent, are being increasingly identified. 10 Moreover, these complications, including migration of stent, cholangitis, pancreatitis, cholecystitis, and obstruction of the stent, may prove fatal to patients with a short life expectancy.…”
mentioning
confidence: 99%
“…[1][2][3][4] As a result of advancements in therapeutic ERCP and the development of a variety of metal stents, [5][6][7][8][9] complications after stent procedures, although not frequent, are being increasingly identified. 10 Moreover, these complications, including migration of stent, cholangitis, pancreatitis, cholecystitis, and obstruction of the stent, may prove fatal to patients with a short life expectancy.…”
mentioning
confidence: 99%
“…For example, zoledronic acid in combination with chemotherapy can reduce skeleton related events in non-small cell lung cancer patients (Coleman et al, 2010). Percutaneous placement of metal stents to patients with malignant biliary obstruction were beneficial with regard to survival time (O'Brien et al, 1995). Analgesic can substantially reduce patient's suffering.…”
Section: Discussionmentioning
confidence: 99%
“…Long-term biliary drainage continues to be a challenge and modifications to stent design have not proven to be an effective solution [3,4,11]. SEMS have been shown to offer longer palliation than plastic stents but can occlude due to tumor growth, sludge or biofilm formation.…”
Section: Discussionmentioning
confidence: 99%
“…SEMS can occlude from tissue ingrowth or overgrowth, benign epithelial hyperplasia or secondary to biofilm, and sludge formation within the lumen of the stent [3]. Up to 50% of patients will have stent occlusion in the first 6 to 8 months [4,5]. Different design alternatives have been explored in an attempt to improve stent patency.…”
Section: Introductionmentioning
confidence: 99%